Discussion:
Blood culture-negative IE has a high variation in prevalence among
countries; the reports vary from 2.5- 70% of all infective endocarditis
based on zoonotic agent exposure, antibiotic prescription pattern, and
diagnostic tools (10).
Bartonella species are among the main microorganisms in culture-negative
endocarditis. Meanwhile, among all 45 known Bartonella species, B.
henselae is the second most common cause of culture-negative
endocarditis(11). While cats and cat-scratch are considered the main
reservoir of B. henselae, dogs could also transmit infection as
accidental hosts(12).
Moreover, although Bartonella endocarditis is a worldwide issue and
there are case reports from all parts of the world, most reported cases
are from European countries and the Americas(11).
In this article, we are reporting a case of Bartonella endocarditis in
Iran; it is notable that since Bartonella endocarditis is not common in
Iran, usually physician does not put this agent on the list of their
differential diagnosis, which causes several challenges to achieving a
timely diagnosis and treatment of Bartonella endocarditis. Besides, the
final diagnosis is even more challenging due to non-specific symptoms,
which are the same as other subacute endocarditis or infective
syndromes.
Moreover, the diagnosis is more challenging during the COVID-19 pandemic
and the similarity between the typical symptoms of SARS-CoV-2 and
endocarditis (13). Nevertheless, several diagnostic tools are available;
despite their limitations, such as low specificity and cross-reactions,
serology is still considered valuable in diagnosing Bartonella
endocarditis(14). Also, PCR testing on whole blood or plasma specimen,
with approximate sensitivity of 58% and specificity of 100%, is an
effective diagnostic tool(15).
In this case, the patient had a history of contact with dogs, but based
on previous studies, connection with cats is more common in most B.
henselae endocarditis cases.
Moreover, in the current case, one of the first complaints of the
patient was exertional dyspnea, and heart failure manifestations are
considered an acute coronary syndrome. At the same time, based on the
study conducted by Okaro et al., approximately 50 to 70% of Bartonella
endocarditis presents symptoms of heart failure, including exertional
dyspnea(11).
Low socioeconomic status is one of the underlying determinants of
developing B. quintana endocarditis. While in our patient, who was
diagnosed with B. henselae, the patient’s social history regarding
IV-drug abuse and low socioeconomic status were the most important
considerations (11). Also, prognosis and treatment must consider
epidemiological exposure and alternate diagnoses for culture-negative
endocarditis in individuals who don’t respond to therapy.
The authors of the article include: Sara Gaderkhani, Bahar Haghdoost,
Amirhossein Eghbal, Mahsa Azadbakhsh Kanafgorabi, Saharnaz Sazgarnejad,
Saber Esmaeili, Arash Seifi, Ensiyeh Rahimi.
S.Ghaderkhani, A.Seifi and E.Rahimi contributed to the conception and
design of this report. The case was diagnosed and followed up by S.
Sazgarnejad and S.Esmaeili. B.Haghdoost, A.Eghbal, M.Azaadbakhsh and
S.Sazgarnejad participated in data collection. B.Haghdoost, A.Eghbal and
M.Azaadbakhsh wrote the article. All authors contributed to data
interpretation, critically reviewed the article and approved the final
draft for submission.
This manuscript is original, is not published, in press, or submitted
elsewhere in English or any other language and is not currently being
considered for publication elsewhere.
All authors have seen and approved the content of the manuscript and
have contributed significantly to the work.
This study has been approved by the ethics committee of Tehran
University of Medical. Sciences, adheres to the Declaration of Helsinki
and informed consent was taken.
The patient has given a written informed consent for the publication.
The authors confirm that written consent has been obtained from the
patient for submission and publication.
All the patient’s data and materials are provided in the manuscript.
The authors declare that they have no competing interests.
Funding do not applicable in this manuscript.
1. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K.
Epidemiologic aspects of infective endocarditis in an urban population.
A 5-year prospective study. Medicine. 1995;74(6):324-39.
2. Yew HS, Murdoch DR. Global trends in infective endocarditis
epidemiology. Current infectious disease reports. 2012;14(4):367-72.
3. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, et al.
Clinical presentation, etiology, and outcome of infective endocarditis
in the 21st century: the International Collaboration on
Endocarditis–Prospective Cohort Study. Archives of internal medicine.
2009;169(5):463-73.
4. Tunkel AR, Kaye D. Endocarditis with negative blood cultures. Mass
Medical Soc; 1992. p. 1215-7.
5. Van Scoy R, editor Culture-negative endocarditis. Mayo Clinic
Proceedings; 1982.
6. Katsouli A, Massad MG. Current issues in diagnosing and managing
blood culture-negative infective and non-infective endocarditis. The
Annals of Thoracic Surgery. 2013;95(4):1467-74.
7. Patel R, Call M, Schnee A. A case of Bartonella henselae native valve
endocarditis presenting with crescentic glomerulonephritis. IDCases.
2022;27:e01366.
8. Chomel BB, Kasten R, Williams C, Wey A, Henn J, Maggi R, et al.
Bartonella endocarditis: a pathology shared by animal reservoirs and
patients. Annals of the New York Academy of Sciences.
2009;1166(1):120-6.
9. Houpikian P, Raoult D. Blood culture-negative endocarditis in a
reference center: etiologic diagnosis of 348 cases. Medicine.
2005;84(3):162-73.
10. Fournier PE, Gouriet F, Casalta JP, Lepidi H, Chaudet H, Thuny F, et
al. Blood culture-negative endocarditis: Improving the diagnostic yield
using new diagnostic tools. Medicine (Baltimore). 2017;96(47):e8392.
11. Okaro U, Addisu A, Casanas B, Anderson B. Bartonella Species, an
Emerging Cause of Blood-Culture-Negative Endocarditis. Clin Microbiol
Rev. 2017;30(3):709-46.
12. Chomel BB, Boulouis HJ, Maruyama S, Breitschwerdt EB. Bartonella
spp. in pets and effect on human health. Emerg Infect Dis.
2006;12(3):389-94.
13. Arbune M, Iancu AV, Lupasteanu G, Vasile MC, Stefanescu V. A
Challenge of COVID-19: Associated Infective Endocarditis with
Streptococcus gordonii in a Young Immunocompetent Patient. Medicina
(Kaunas). 2021;57(12).
14. Barka NE, Hadfield T, Patnaik M, Schwartzman WA, Peter JB. EIA for
detection of Rochalimaea henselae-reactive IgG, IgM, and IgA antibodies
in patients with suspected cat-scratch disease. J Infect Dis.
1993;167(6):1503-4.
15. Sanogo YO, Zeaiter Z, Caruso G, Merola F, Shpynov S, Brouqui P, et
al. Bartonella henselae in Ixodes ricinus ticks (Acari: Ixodida) removed
from humans, Belluno province, Italy. Emerg Infect Dis.
2003;9(3):329-32.